PepGen (PEPG) stock forecast for 2027
Last update: December 3, 2022 (08:05)
Sector: HealthcareThe share price of PepGen Inc. (PEPG) now
What analysts predict: $22.5
52-week high/low: $17.81 / $4.32
50/200 Day Moving Average: $11.34 / $10.88
This figure corresponds to the average price over the previous 50/200 days. For PepGen stocks, the 50-day moving average is the support level today.
For PepGen stocks, the 200-day moving average is the support level today.
Are you interested in PepGen stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the PepGen stock price in 2027. How much will one PepGen share be worth in 2027?
Is it worth taking profit / loss on PepGen stock now or waiting? What are analysts' forecasts for PepGen stock?
We forecast PepGen stock performance using neural networks based on historical data on PepGen stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
The PepGen stock prediction results are shown below and presented as a graph, table and text information.
PepGen stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for PepGen analysts is $22.5.
Today 200 Day Moving Average is the support level (10.88 $).
50 Day Moving Average is the support level (11.34 $).
Historical and forecast chart of PepGen stock
The chart below shows the historical price of PepGen stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the PepGen stock price can be found in the table below.
PepGen (PEPG) Forecast for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 58.63 | 55.94 | 62.27 | 10.17 % |
| Feb | 55.47 | 50.70 | 60.24 | 15.84 % |
| Mar | 54.80 | 51.19 | 60.83 | 15.86 % |
| Apr | 56.67 | 53.83 | 64.26 | 16.23 % |
| May | 54.51 | 51.02 | 58.76 | 13.17 % |
| Jun | 56.58 | 50.13 | 60.43 | 17.04 % |
| Jul | 53.19 | 46.17 | 55.85 | 17.33 % |
| Aug | 49.78 | 43.01 | 55.96 | 23.13 % |
| Sep | 50.28 | 47.97 | 55.61 | 13.74 % |
| Oct | 45.35 | 39.73 | 47.62 | 16.57 % |
| Nov | 41.45 | 36.31 | 43.28 | 16.09 % |
| Dec | 38.80 | 34.61 | 41.98 | 17.56 % |
PepGen information and performance
PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded in March 26, 2018 and is headquartered in Cambridge, MA.
PepGen Address
245 MAIN STREET, CAMBRIDGE, MA, UNITED STATES
Market Capitalization: 330 847 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: -57 903 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
DPS: N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: -42.34
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: -
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: -
Enterprise Value (EV) /Revenue
EV To EBITDA: -2.647
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 23631900
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
PepGen price target for 2027 by month
Target values for the price of one PepGen share for Jan 2027.
Pessimistic target level: 55.94
Optimistic target level: 62.27
Target values for the price of one PepGen share for Feb 2027.
Pessimistic target level: 50.70
Optimistic target level: 60.24
Target values for the price of one PepGen share for Mar 2027.
Pessimistic target level: 51.19
Optimistic target level: 60.83
Target values for the price of one PepGen share for Apr 2027.
Pessimistic target level: 53.83
Optimistic target level: 64.26
Target values for the price of one PepGen share for May 2027.
Pessimistic target level: 51.02
Optimistic target level: 58.76
Target values for the price of one PepGen share for Jun 2027.
Pessimistic target level: 50.13
Optimistic target level: 60.43
Target values for the price of one PepGen share for Jul 2027.
Pessimistic target level: 46.17
Optimistic target level: 55.85
Target values for the price of one PepGen share for Aug 2027.
Pessimistic target level: 43.01
Optimistic target level: 55.96
Target values for the price of one PepGen share for Sep 2027.
Pessimistic target level: 47.97
Optimistic target level: 55.61
Target values for the price of one PepGen share for Oct 2027.
Pessimistic target level: 39.73
Optimistic target level: 47.62
Target values for the price of one PepGen share for Nov 2027.
Pessimistic target level: 36.31
Optimistic target level: 43.28
Target values for the price of one PepGen share for Dec 2027.
Pessimistic target level: 34.61
Optimistic target level: 41.98